You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative%20Disorders

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epidemiological and Clinical-pathological Factors of

Completed
  • Myeloproliferative Neoplasm
  • +4 more
    • Guayaquil, Guayas, Ecuador
      Sociedad de Lucha Contra el Cáncer
    Apr 25, 2023

    Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

    Not yet recruiting
    • Myeloproliferative Disorders
    • +3 more
    • (no location specified)
    Nov 21, 2023

    Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)

    Not yet recruiting
    • Myeloproliferative Disorders
    • Leukemia
    • Cardiac Lifestyle Program
    • Boston, Massachusetts
    • +2 more
    May 1, 2023

    Myeloproliferative Tumors Trial (INCA033989)

    Not yet recruiting
    • Myeloproliferative Neoplasms
    • (no location specified)
    Sep 11, 2023

    Epigenetic Age on Clinic-biological Presentation and Prognosis

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Assessment of the epigenetic age
    • Bordeaux, France
      CHU de Bordeaux, service Hématologie Biologique
    Aug 28, 2023

    Carotid Plaque Burden in Philadelphia Negative

    Recruiting
    • Myeloproliferative Neoplasm
      • Sohag, Egypt
        Faculty of Medicine
      Aug 14, 2023

      Action of Interferon in Treatment of Myeloproliferative

      Recruiting
      • Myeloproliferative Neoplasm
        • Villejuif, Ile De France, France
          Inserm U1287
        Apr 28, 2023

        Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

        Recruiting
        • Myeloproliferative Neoplasm
        • +7 more
          • Hong Kong, Hong Kong
            Department of Medicine, Queen Mary Hospital
          May 21, 2023

          Healthy Volunteers of Fanconi Anemia, Myeloproliferative

          Completed
          • Chronic Myeloproliferative Disorders
          • +3 more
          • microarray analysis
          • +8 more
          • Portland, Oregon
            Knight Cancer Institute at Oregon Health and Science University
          Jun 30, 2022

          Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

          Not yet recruiting
          • Acute Myeloid Leukemia
          • +5 more
          • Cytokine Induced Memory-like Natural Killer Cells
          • Interleukin-2
          • Boston, Massachusetts
          • +1 more
          Nov 14, 2023

          Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

          Not yet recruiting
          • Myeloproliferative Neoplasms (MPNs)
          • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
          • (no location specified)
          Mar 24, 2023

          Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

          Not yet recruiting
          • Myeloproliferative Neoplasm
          • Secondary Leukemia
          • Multiomic characterization
          • In vitro drug screening
          • (no location specified)
          Aug 28, 2023

          Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

          Not yet recruiting
          • Immune System Diseases
          • +15 more
          • observational cohort study
          • (no location specified)
          Jul 23, 2023

          Myeloproliferative Tumor, Optical Genome Mapping, Cytogenetics Trial in Amiens (Blood sample)

          Recruiting
          • Myeloproliferative Neoplasm
          • +4 more
          • Blood sample
          • Amiens, Picardie, France
            Centre Hospitalier Universitaire d'Amiens
          Jan 27, 2023

          Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

          Recruiting
          • Myeloproliferative Neoplasm
          • Fedratinib Pill
          • Tampa, Florida
            Moffitt Cancer Center
          Nov 28, 2022

          Pathogenesis of Hematologic Malignancies

          Enrolling by invitation
          • Acute Leukemia
          • +3 more
          • blood draw, bone marrow procedure, or tissue biopsy
          • Portland, Oregon
            OHSU Knight Cancer Institute
          Sep 9, 2022

          Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

          Active, not recruiting
          • Myeloproliferative Neoplasm
          • +4 more
          • Orange, California
            Chao Family Comprehensive Cancer Center, University of Californi
          Jan 6, 2023

          Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

          Not yet recruiting
          • Myelofibrosis (PMF)
          • +2 more
          • New York, New York
            Ruttenberg Treatment Center
          Apr 18, 2023

          Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

          Withdrawn
          • Accelerated Phase MPN
          • Blast Phase MPN
          • (no location specified)
          Nov 4, 2022

          Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

          Completed
          • Myelodysplastic/Myeloproliferative Neoplasm
          • +2 more
          • Decidual stromal cells (DSC)
          • Toronto, Ontario, Canada
            Princess Margaret Cancer Centre
          Jan 8, 2023

          Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

          Active, not recruiting
          • Acute Myeloid Leukemia
          • +9 more
          • Los Angeles, California
          • +5 more
          Jan 27, 2023

          Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

          Not yet recruiting
          • Bone Marrow Fibrosis
          • Myeloproliferative Neoplasm
          • Cleveland, Ohio
            Cleveland Clinic, Case Comprehensive Cancer Center
          Jan 30, 2023

          Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

          Not yet recruiting
          • Myeloid Malignancy
          • +4 more
          • Telehealth Serious Illness Care Program
          • Education Control
          • Rochester, New York
            University of Rochester
          May 24, 2023

          Monocytes Sub-populations in Thrombosis Associated With

          Recruiting
          • Myeloproliferative Neoplasm
          • 1 additional tube of blood
          • Bordeaux, France
          • +4 more
          Nov 30, 2022

          Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

          Recruiting
          • Myeloproliferative Neoplasm
          • +3 more
          • CALR allele burden quantification
          • Angers, France
            CHU Angers
          Nov 2, 2022